Latest AI and machine learning research in hemophilia for healthcare professionals.
OBJECTIVE: Pancreatic cancer (PC) poses a significant threat to patient quality of life. Ferroptosis, a novel form of non-apoptotic cell death, is implicated in pancreatic tumorigenesis and therapy resistance. This study aims to identify key ferroptosis-related genes (FRGs) as prognostic biomarkers, to construct a risk model for predicting patient outcomes, and to explore the underlying biological...
Developing potent, selective small-molecule inhibitors remains a major challenge in drug discovery. ALDH3A1, a detoxifying aldehyde dehydrogenase isoform implicated in cancer and neurodegeneration, is a promising yet underexplored therapeutic target. To accelerate inhibitor optimization, we developed an AI-guided, reaction-based hit-to-lead workflow combining sequential reaction enumeration, pharm...
Pseudomonas aeruginosa is a leading cause of nosocomial infections, particularly in individuals with a compromised immune system. Due to its strong ad...
Despite robust preclinical evidence, many clinical trials, including several that targeted the purinergic system, fail to demonstrate efficacy in huma...
Cyclosporine A (CsA) functions as a calcineurin inhibitor that perturbs T cell activation via calcineurin-nuclear factor of activated T cells (CaN-NFA...
BACKGROUND: Environmental cadmium (Cd) pollution poses a severe threat to human health due to its strong bioaccumulation and high carcinogenicity. Alt...
Systemic therapy for hepatocellular carcinoma (HCC) has undergone rapid transformation over the past decade, significantly expanding treatment options...
BACKGROUND: Metabolic syndrome (MetS) is an emerging complication among people living with HIV (PLHIV) receiving long-term antiretroviral therapy (ART...
This review systematically analyzes the relationship between the immune microenvironment characteristics of microsatellite instability-high (MSI-H) or...
Seen as a problem of guided exploration with multiple objectives, molecular design requires carefully elaborated decision-tree-based strategies for tr...
BACKGROUND: Immune checkpoint inhibitors (ICIs) significantly improve cancer outcomes but can cause rare, potentially fatal cardiotoxicity, including ...
Leucine-rich repeat kinase 2 (LRRK2) has emerged as an attractive molecular target for Parkinson's disease therapeutics. To discover novel and potent ...
PURPOSE: To investigate the prognostic value of an artificial intelligence (AI)-based semi-automated tool for longitudinal whole-body quantification o...
The gut microbiota appears to play a critical role in modulating antitumor immune responses and influencing the efficacy of cancer immunotherapy drugs...
Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with limited targeted treatment options and poor clinical outcomes. We developed...
INTRODUCTION: Readily available predictive biomarkers for immune checkpoint inhibitor (ICI) response in advanced melanoma are limited. This study eval...
It is imperative to develop precise detection tools for enzymes, as key biomarkers in disease pathogenesis, to fuel progress in clinical diagnostics a...
Molecular heterogeneity in head and neck squamous cell carcinoma (HNSCC) is well recognized, yet existing subtype frameworks remain largely descriptiv...
Aging is a well-recognized risk factor in cardiovascular diseases (CVDs), primarily due to its association with the gradual decline in cardiac functio...
The rational design of novel MDM2 inhibitors with superior biochemical properties represents the most consequential outcome of contemporary computer-a...